Calls For Cough/Cold Collaboration As FDA Inches Toward Rulemaking
This article was originally published in The Tan Sheet
Executive Summary
As FDA embarks on a lengthy rulemaking process to address pediatric OTC cough/cold products, the agency has strategies outside the regulatory framework available to effect any more immediate changes it deems necessary
You may also be interested in...
FDA Nonprescription Office Adding Staff To Focus On Monograph Work
FDA's Division of Nonprescription Regulation Development will hire additional staff to accelerate monograph work and enhance the office's internal expertise
FDA Nonprescription Office Adding Staff To Focus On Monograph Work
FDA's Division of Nonprescription Regulation Development will hire additional staff to accelerate monograph work and enhance the office's internal expertise
FDA Nonprescription Office Adding Staff To Focus On Monograph Work
FDA's Division of Nonprescription Regulation Development will hire additional staff to accelerate monograph work and enhance the office's internal expertise